We are excited to announce the 2022 cohort of Praxis SCI Accelerate, a 12 week…
pthomsonJune 30, 2022
Congratulations to the winners of the 2022 Djavad Mowafaghian Centre for Brain Health Trainee Endowment…
pthomsonJune 29, 2022
Approved drugs for the treatment of osteoporosis can prevent further bone loss but do not…
pthomsonJune 29, 2022
STEMCELL Technologies, Canada’s largest biotechnology company, announced today that it has received ISO 14001:2015 certification…
pthomsonJune 28, 2022
Clinical trials are essential scientific studies that evaluate the safety, effectiveness, and outcomes of health…
pthomsonJune 28, 2022
Sixty-one UBC Science faculty members have received a total of $13.6 million in Natural Sciences…
pthomsonJune 28, 2022
Faculty of medicine researchers were awarded more than $3.9 million in funding from the Natural Sciences…
pthomsonJune 27, 2022
AbCellera and Harbour Antibodies, a Harbour BioMed subsidiary, enter into an agreement to combine AbCellera’s…
sciencecityJune 8, 2018
Microbiome Insights, Inc. has announced the opening of its new laboratory on the campus of…
sciencecityJune 7, 2018
’m a professor of medicine in the division of hematology-oncology, and the director of the…
sciencecityJune 5, 2018
Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced…
sciencecityJune 4, 2018
Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced…
mjoyJune 4, 2018
Glaucoma is an eye disease that is often associated with elevated intraocular pressure leading to…
sciencecityJune 1, 2018
Historically, heparins were the mainstay of anticoagulant therapy. They were the primary agents used to…
sciencecityMay 31, 2018
Studying partners’ habits leads researchers to breakthrough in kidney stone research. Kidney stones are a…
sciencecityMay 30, 2018
